Walgreens Infusion Services selected as preferred provider for Makena
DEERFIELD, Ill. — Walgreens Infusion Services on Monday announced that it has been selected as the preferred provider of home administration services for Makena (hydroxyprogesterone caproate injection), the only FDA-approved medication to help reduce the risk of preterm birth for clinically indicated patients. Makena is a progestin indicated to reduce the risk of preterm birth in women with a singleton pregnancy who have a history of singleton spontaneous preterm birth.
The new initiative, Makena @Home, creates access to weekly administration of the only FDA-approved medication for this indication in the home setting when covered by the patient’s insurance, providing an important option for patients and their healthcare providers. The program provides home administration of Makena by trained nurses, along with patient assessment and personalized care plan development, reimbursement/coverage coordination for home administration of therapy and scheduling and administrative support for patients.
“Makena is an important treatment for women at risk for recurrent preterm birth,” said Paul Mastrapa, president of Walgreens Infusion Services. “Makena @Home allows our expert multidisciplinary teams to care for patients in a comfortable and convenient location for them. We’re proud to add Makena @Home to the services we provide to patients in their homes and at alternate treatment sites nationwide each day.”
“Selecting Walgreens Infusion Services for Makena @Home gives us confidence that patients who need their weekly injections of FDA-approved Makena administered at home are receiving high-quality care,” said Greg Divis, CEO of K-V Pharmaceutical Company. “We’re excited to collaborate with a well-respected and widely recognized partner in Walgreens to provide this important option for the patients and providers we work with every day.”
Makena is administered by a healthcare provider as a single dose into the hip area (upper outer area of the buttocks) once a week, rotating sides each week. The goal of a healthy pregnancy is to deliver at term — at least 37 weeks of pregnancy. Makena is the only FDA-approved treatment that may help patients who have delivered preterm in the past stay pregnant longer.
ScriptCycle expands solutions for retail pharmacies
ASHEVILLE, N.C. — ScriptCycle, a technology company that serves pharmacies and patients, will launch its comprehensive cash solutions for retail pharmacies at the NACDS Regional Conference in February. The products aim to help pharmacies address challenges related to their cash prescription business, the company said.
ScriptCycle said its business model has produced average per-store savings of $7,000 to $12,000 per year.
"Our business model is simple, really. When pharmacies save money, patients save money," said Phil Trunnell, CEO of Scriptcycle. "Scriptcycle¹s focus is to provide pharmacy solutions that increase margins and translate patient value into patient loyalty. We look forward to explaining our company to more pharmacy chains at the NACDS Regional Conference."
The NACDS Regional Conference will be held in Naples, Fla., from Feb. 2 to Feb. 5 at the Ritz Carlton. ScriptCycle will be available for meetings at table No. 121.
NACDS Foundation awards scholarships to four pharmacy students
ARLINGTON, Va. — The National Association of Chain Drug Stores Foundation announced on Friday the recipients of the Pharmacy Student Scholarship Awards.
The NACDS Foundation awarded $5,000 each to four pharmacy students. The recipients were chosen for their work that shares the NACDS Foundation’s commitment to benefit patients, improve outcomes and advance public health.
“We are pleased to recognize the work of these high-caliber pharmacy students by awarding each of them the NACDS Foundation Pharmacy Student Scholarship Award,” stated NACDS Foundation president Kathleen Jaeger. “Each exemplifies one of the key missions of the NACDS Foundation in supporting pharmacy education programs that focus on patient-centered care in the community pharmacy setting, and we applaud them for their academic accomplishments.”
The recipients are:
- Jessica Carver, Samford University McWhorter School of Pharmacy. Through active participation and leadership in her school pharmacy organizations, Carver has demonstrated an interest in advocating for issues that advance patient care in the community pharmacy setting.
- Katherine Fischer, University of the Incarnate Word Feik School of Pharmacy. Understanding change is needed in the delivery of patient care services, Fischer’s vision of pharmacy includes an expansion of clinical services and health testing in community practice, as well as increased engagement in community outreach.
- Erin Schaffer, University of Toledo College of Pharmacy. Schaffer has demonstrated a commitment to public health, and has a positive vision for the expansion of the role of medication management in meeting patients’ healthcare needs and improving pharmaceutical care and outcomes.
- Kyle Townswick, University of Minnesota College of Pharmacy. Townswick, a Pharm.D./MBA student, has demonstrated an interest in care coordination and is dedicated to improving the patient’s experience.